1. A Model to predict severity of drug‐induced liver injury in humans. Issue 3 (27th July 2016) Authors: Chen, Minjun; Borlak, Jürgen; Tong, Weida Journal: Hepatology Issue: Volume 64:Issue 3(2016:Sep.) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies. Issue 1 (January 2022) Authors: Wu, Yue; Xiao, Wenzhong; Tong, Weida; Borlak, Jürgen; Chen, Minjun Journal: Drug discovery today Issue: Volume 27:Issue 1(2022) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Issue 4 (April 2016) Authors: Chen, Minjun; Suzuki, Ayako; Thakkar, Shraddha; Yu, Ke; Hu, Chuchu; Tong, Weida Journal: Drug discovery today Issue: Volume 21:Issue 4(2016) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Drug-Induced Liver Injury. (9th January 2017) Authors: Almario, Eileen E. N.; Borlak, Jürgen; Suzuki, Ayako; Chen, Minjun Journal: BioMed research international Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Drug-Induced Liver Toxicity. (2018) Editors: Chen, Minjun; Will, Yvonne Record Type: Book Extent: 1 online resource (667 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug‐induced liver injury1234. Issue 1 (27th May 2013) Authors: Chen, Minjun; Borlak, Jürgen; Tong, Weida Journal: Hepatology Issue: Volume 58:Issue 1(2013:Jul.) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Integrative approaches for studying the role of noncoding RNAs in influencing drug efficacy and toxicity. (1st February 2022) Authors: Li, Dongying; Chen, Minjun; Hong, Huixiao; Tong, Weida; Ning, Baitang Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 18:Number 2(2022) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. (5th September 2016) Authors: Atienzar, Franck A.; Blomme, Eric A.; Chen, Minjun; Hewitt, Philip; Kenna, J. Gerry; Labbe, Gilles; Moulin, Frederic; Pognan, Francois; Roth, Adrian B.; Suter-Dick, Laura; Ukairo, Okechukwu; Weaver, Richard J.; Will, Yvonne; Dambach, Donna M. Other Names: Leo Hwa-Liang Academic Editor. Journal: BioMed research international Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis. (November 2015) Authors: Wu, Leihong; Liu, Zhichao; Xu, Joshua; Chen, Minjun; Fang, Hong; Tong, Weida; Xiao, Wenming Journal: Biomarkers in medicine Issue: Volume 9:Number 11(2015) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nrf-2-driven long noncoding RNA ODRUL contributes to modulating silver nanoparticle-induced effects on erythroid cells. (June 2017) Authors: Gao, Ming; Zhao, Beibei; Chen, Minjun; Liu, Yun; Xu, Ming; Wang, Zhe; Liu, Sijin; Zhang, Chengdong Journal: Biomaterials Issue: Volume 130(2017) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗